News
BCTXW
0.0009
0.00%
0.00
Weekly Report: what happened at BCTX last week (1026-1030)?
Weekly Report · 6h ago
Weekly Report: what happened at BCTX last week (1019-1023)?
Weekly Report · 10/26 09:06
BriaCell Highlights New Immune Biomarker Data in Metastatic Breast Cancer at ESMO 2026
TipRanks · 10/23 12:08
BriaCell presents clinical biomarker findings from MBC patients at ESMO
TipRanks · 10/23 11:51
Weekly Report: what happened at BCTX last week (1012-1016)?
Weekly Report · 10/19 09:06
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 10/15 12:12
Weekly Report: what happened at BCTX last week (1005-1009)?
Weekly Report · 10/12 09:07
BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting
Barchart · 10/06 06:30
Weekly Report: what happened at BCTX last week (0928-1002)?
Weekly Report · 10/05 09:07
Weekly Report: what happened at BCTX last week (0921-0925)?
Weekly Report · 09/28 09:06
Weekly Report: what happened at BCTX last week (0914-0918)?
Weekly Report · 09/21 09:06
BriaCell announces DSMB recommendation to continue Bria-ABC study
TipRanks · 09/14 11:35
Weekly Report: what happened at BCTX last week (0907-0911)?
Weekly Report · 09/14 09:07
Memorial Sloan Kettering Cancer Center Joins BriaCell’s Ongoing Pivotal Phase 3 Study Of Bria-IMT Plus Immune Checkpoint Inhibitor In Metastatic Breast Cancer
Benzinga · 09/08 11:35
Weekly Report: what happened at BCTX last week (0831-0904)?
Weekly Report · 09/07 09:06
Weekly Report: what happened at BCTX last week (0824-0828)?
Weekly Report · 08/31 09:07
BriaCell Advances Off-the-Shelf Personalized Melanoma Vaccine Toward Clinic
TipRanks · 08/24 12:11
BriaCell Therapeutics Advances Bria-MEL+ Whole Cell Melanoma Immunotherapy Vaccine Candidate Toward Clinical Development With Key Genetic Engineering Milestone
Benzinga · 08/24 11:33
Weekly Report: what happened at BCTX last week (0817-0821)?
Weekly Report · 08/24 09:07
Weekly Report: what happened at BCTX last week (0810-0814)?
Weekly Report · 08/17 09:07
More
Webull provides a variety of real-time BCTXW stock news. You can receive the latest news about Briacell Therapeutics Corp through multiple platforms. This information may help you make smarter investment decisions.
About BCTXW
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops immunotherapies to transform cancer care. The Company’s lead drug candidate, Bria-IMT, is a cell-based patented immunotherapy that stimulates a patient’s own cancer fighting cells to attack and destroy breast cancer tumors. The Company is advancing its targeted immunotherapy program by prioritizing a Phase II clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor. The Company is focused on conducting a Phase I/IIa clinical trial of Bria-IMT in a combination study with Incyte’s immune PD-1 inhibitor, retifanlimab, in advanced breast cancer. The Company is also developing Bria-OTS, an off-the-shelf personalized approach to whole cell cancer immunotherapy. The Bria-OTS immunotherapy is based on a patient’s HLA-type. Its pipeline also includes Bria-Pros, Bria-Lung, Bria-Mel and sCD80, which are in development to treat various cancers.